Rani Therapeutics Holdings (RANI) Non Operating Interest Expenses (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted Non Operating Interest Expenses of $8,000 for Q2 2026, down 99.1% from $877,000 a year earlier and down 90.9% from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Rani Therapeutics Holdings was $1.17 million, down 72.7% year-over-year; for FY2025, it came in at $2.89 million, down 42.6% from FY2024.
- Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of 87.7% (FY2020 to FY2025).
- In prior years, Rani Therapeutics Holdings' Non Operating Interest Expenses was $5.03 million in FY2024 (-1.0%), $5.09 million in FY2023 (+374.8%), $1.07 million in FY2022 (+129.8%) and $466,000 in FY2021 (+275.8%).
- The Q2 2026 figure stands as the lowest quarterly Non Operating Interest Expenses since Q4 2021.
- On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last seven quarters, with an average decline of 46.8% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q3 2023, with growth of 273.9%; the weakest was Q2 2026, with a decline of 99.1%.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $88,000 (Q1 2026), $347,000 (Q4 2025) and $725,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Rani Therapeutics Holdings | 147.86 Mn | 156.61 Mn | - | 8,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 347,000.00 |
| Sep 30, 2025 | 725,000.00 |
| Jun 30, 2025 | 877,000.00 |
| Mar 31, 2025 | 943,000.00 |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.29 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 110,000.00 |
| Jun 30, 2021 | 169,000.00 |
| Mar 31, 2021 | 188,000.00 |
API Access
Rani Therapeutics Holdings Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();